Investing First patient dosed in Phase IIb imaging for Brain Mets April 28, 2025 Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post RHI: Acqn of royalty over Sandstone Gold Project tenements April 28, 2025 Related Posts Sun Summit Announces Upsized Non-Brokered Private Placement of up to $11.5 Million December 13, 2025 Top 5 Canadian Mining Stocks This Week: Sirios Resources Gains 120 Percent December 13, 2025 Contango ORE, Dolly Varden Announce Strategic Silver Merger December 13, 2025
